medigraphic.com
SPANISH

Multimed

ISSN 1028-4818 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 1

<< Back Next >>

Mul Med 2015; 19 (1)

Predicting echographic variables of malignity in hepatic tumours

Rodríguez SCM, Guerra CHR, Rodríguez GMJ, Cedeño TY
Full text How to cite this article

Language: Spanish
References: 13
Page:
PDF size: 181.65 Kb.


Key words:

liver neoplasms/ultrasonography.

ABSTRACT

It was performed an observational, analytical and cohort study at the Central Hospital of the Nampula province, in Mozambique, between the 2012-2013; with the aim to determine some echographic variables, hypothetically related with the diagnostic of malignancy of the hepatic tumor. The universe was constituted by 121 patients diagnosed with liver tumor, through the abdominal echography. The sample was constituted by 109 patients. For the analysis of the echographic variables probably associated to the malignancy of the liver tumor, there were established comparisons with the anatomopathological study. It was used the X2 (Chi square) test, with a significance level of 0, 05; it was estimated the magnitude of the associations by means of the calculation of the relative risk (RR). The patients with heterogeneous injuries showed greater possibilities for the anatomopathological malignant confirmation. The level of echogenicity and the size of the injury were not presented according to the anatomopathological diagnosis. The patients with multiple hepatic injuries duplicated the possibilities of malignancy. The echography evidenced anatomopathological agreement for the greatest part of the positive cases of malignancy.


REFERENCES

  1. Hashem B. El-Serag HB. Hepatocellular Carcinoma. N Engl J Med [Internet]. 2011 [citado 22 Sep 2013]; 365:1118-1127. Disponible en http://www.nejm.org/doi/full/10.1056/NEJMra1001683.

  2. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat database: incidence — SEER 9 Regs research data, Nov 2009 Sub (1973-2007). Bethesda, MD: National Cancer Institute, Abril 2010.

  3. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology [Internet]. 2011[citado 22 Sep 2013]; 53(3): 1020-2. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084991/.

  4. Soza A. Hepatocarcinoma. [Internet]. sa [Citado 12 Nov 2011]. Disponible en: http://www.cirugest.com/htm/revisiones/cir17-06/cir17-06.htm.

  5. Hussain SM, Semelka RC. Hepatic imaging: comparison of modalities. Radiol Clin N Am. 2005. 43(5): 929 – 47.

  6. Yoon SS, Tanabe TK. Surgical treatment and other regional treatments for colorectal liver metastases. Oncologists [Internet]. 1999 [citado 22 Sep 2013]; 4 (3): 197-208. Disponible en: http://theoncologist.alphamedpress.org/content/4/3/197.long

  7. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring based population based trends in cancer treatment. J Natl Cancer Inst [Internet]. 2005 [citado 22 Sep 2013]; 97(19): 1407-27. Disponible en: http://jnci.oxfordjournals.org/content/97/19/1407.long

  8. Remontet L, Estève J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period of 1978-2000. Rev d´Epidemiol Santé Publique. 2003; 51(1):3-30.

  9. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2):74-108.

  10. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor Robinson SD. Hepatocelular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterology [Internet]. 2008 [citado 22 Sep 2013]; 14(27):4300-8. Disponible en: http://www.wjgnet.com/1007-9327/full/v14/i27/4300.htm

  11. Fernández Rodríguez V, Paz Martínez C, Gómez-Ulla Astray D, Graña Fernández S. Apuntes de ecografía. Hígado (III): Lesiones focales. Cad Aten Primaria [Internet]. 2009 [citado 22 Sep 2013]; 16(1): 48-59. Disponible en: http://www.agamfec.com/antiga2013/pdf/CADERNOS/VOL16/n1/05_Habilidades_e_Terapeutica_Higado.pdf

  12. Bayer Schering Pharma. Cáncer de hígado, una de las hepatopatías más graves. [Internet]. sa [Citado 22 Sep 2011]. Disponible en: http://www.imagenesquesalvanvidas.com/scripts/pages/es/public/diseases/cncer/livercancer/index.php

  13. Escrig-Sos J, Martínez-Ramos D, Miralles- Tena JM. Pruebas diagnósticas: nociones básicas para su correcta interpretación y uso. Cir Española [Internet]. 2006 [citado 22 Sep 2013]; 79 (5): 267-73. Disponible en: http://www.elsevier.es/es-revista-ciruga-espaola-36-articulo-pruebas-diagnosticas-nociones-basicas-su-13087491?referer=buscador




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Mul Med. 2015;19